Drug class in one race
SMARCA2 drugs for Non-Small Cell Lung Cancer
3 tracked SMARCA2 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the SMARCA2 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 11 preclinical / unstaged
Head-to-head evidence: LY4050784 vs PRT3789 · PLX-61639 vs PRT3789